semaglutide dry eye case report JAAD Reports published a dedicated Virtual Special Issue focusing on the intersection of GLP-1 agonists and cutaneous disease. We highlight this Case of a 46-year-old woman presented with a 4-year semaglutide dry eye case report

PMID 25331030 randomized, double-blind, placebo-controlled proof-of-concept study in postoperative ileus

If you and your clinician decide to stop, the practical approach is: Step down through the available dose levels at 4-week intervals (12 mg 9 mg 6 mg 4 mg 2 mg off) rather than stopping abruptly

Your skin consists of several layers of cells right on top of each other

A few lifestyle tweaks may help ease bloating, constipation, and nausea and leave you feeling lighter and more energized

Preclinical studies have demonstrated the efficacy of short-acting and the more recent long-acting GLP-1 receptor agonists to reduce alcohol self-administration, relapse-like behaviors, and binge drinking in rodent models (Egecioglu et al